Skip to content
  • Debatforum
  • Seneste
  • Populære
  • Bruger
Temaer
  • Light
  • Dark

Kollaps
FORSIDEN
Log ind Opret konto

Genmab — Maj 2017

Planlagt Fastgjort Låst Flyttet Genmab
1.9k Indlæg 1 Posters 0 Visninger
  • Ældste til nyeste
  • Nyeste til ældste
  • Most Votes
Svar
  • Svar som emne
Login for at svare
Denne tråd er blevet slettet. Kun brugere med emne behandlings privilegier kan se den.
  • P Offline
    P Offline
    Plimsoller
    wrote on sidst redigeret af
    #824

    Så må I tænke jer til hvederne:-)

    1 Reply Last reply
    0
    • E Offline
      E Offline
      E_L
      wrote on sidst redigeret af
      #825

      positive results for durvalumab in non-small cell lung cancer , AstraZeneca +5%
      https://www.astrazeneca.com/content/astraz/media-centre/press-releases/2017/imfinzi-significantly-reduces-the-risk-of-disease-worsening-or-death-in-the-phase-iii-pacific-trial-for-stage-iii-unresectable-lung-cancer-12052017.html

      1 Reply Last reply
      0
      • StockBullS Offline
        StockBullS Offline
        StockBull
        wrote on sidst redigeret af
        #826

        Er durvalumab et Genmab produkt som de samarbejder med AZ om ?

        1 Reply Last reply
        0
        • StockBullS Offline
          StockBullS Offline
          StockBull
          wrote on sidst redigeret af
          #827

          Eller er AZ ved at 'overhale' genmab

          1 Reply Last reply
          0
          • StockBullS Offline
            StockBullS Offline
            StockBull
            wrote on sidst redigeret af
            #828

            Ekker kan man forestille sig durvalumab kan virke bedre i kombination med darzalex

            1 Reply Last reply
            0
            • SolsenS Offline
              SolsenS Offline
              Solsen
              wrote on sidst redigeret af
              #829

              Det sidste 😉

              1 Reply Last reply
              0
              • B Offline
                B Offline
                bibob
                wrote on sidst redigeret af
                #830

                Hellere en åben børs end varme hveder. 🙂

                1 Reply Last reply
                0
                • B Offline
                  B Offline
                  bibob
                  wrote on sidst redigeret af
                  #831

                  StockBull. - https://www.clinicaltrials.gov/ct2/results?term=Daratumumab+-+durvalumab&Search=Search

                  1 Reply Last reply
                  0
                  • BulderB Offline
                    BulderB Offline
                    Bulder
                    wrote on sidst redigeret af
                    #832

                    I NSCLC er dara i et kombiforsøg med atezolizumab, som også er en PD-L1-blokker. https://www.clinicaltrials.gov/ct2/show/NCT03023423?term=luc2001&rank=3

                    1 Reply Last reply
                    0
                    • BulderB Offline
                      BulderB Offline
                      Bulder
                      wrote on sidst redigeret af
                      #833

                      Men AZ er pænt langt fremme med dette fase 3 forsøg.

                      1 Reply Last reply
                      0
                      • E Offline
                        E Offline
                        E_L
                        wrote on sidst redigeret af
                        #834

                        As long as they combine well with Dara, i dont really care which PD-L1 blokker is used... 😉 I even think the more (good) choices, the better, in order to reach as many patie
                        nts as possible?

                        1 Reply Last reply
                        0
                        • SolsenS Offline
                          SolsenS Offline
                          Solsen
                          wrote on sidst redigeret af
                          #835

                          Keytruda er lang fremme https://www.fda.gov/Drugs/InformationOnDrugs/ApprovedDrugs/ucm558048.htm?source=govdelivery&utm_medium=email&utm_source=govdelivery

                          1 Reply Last reply
                          0
                          • G Offline
                            G Offline
                            GeorgeBest
                            wrote on sidst redigeret af
                            #836

                            Dara + Opdivo testes også i NSCLC. se side 9 i vedlagte http://files.shareholder.com/downloads/AMDA-KPIBN/138540251x7895654x942273/927E2A2C-FE48-411B-8753-CB30A0B296E1/Q1_2017_Interim_Report_final.pdf

                            1 Reply Last reply
                            0
                            • E Offline
                              E Offline
                              E_L
                              wrote on sidst redigeret af
                              #837

                              each time i look at the Arzerra royalty of 20%, i have to think of that rumour that the original JNJ deal on Dara also started at 20%....

                              1 Reply Last reply
                              0
                              • H Offline
                                H Offline
                                Hamming
                                wrote on sidst redigeret af
                                #838

                                I går linkede jeg til et studie med JNJ-64007957. Jeg går ud fra, at der er tale om et nyt stof i duobody-samarbejdet med jnj. Hvornår falder der milestones i disse aftaler?

                                1 Reply Last reply
                                0
                                • S Offline
                                  S Offline
                                  Sukkeralf
                                  wrote on sidst redigeret af
                                  #839

                                  Hamming der har været linket til studiet før. Der falder sikkert en milestone når første patient indrulles !

                                  1 Reply Last reply
                                  0
                                  • H Offline
                                    H Offline
                                    Hamming
                                    wrote on sidst redigeret af
                                    #840

                                    Fornemt

                                    1 Reply Last reply
                                    0
                                    • SolsenS Offline
                                      SolsenS Offline
                                      Solsen
                                      wrote on sidst redigeret af
                                      #841

                                      Vi kan også forvente en milestone, når Teprotumumab går i ph3

                                      1 Reply Last reply
                                      0
                                      • U Offline
                                        U Offline
                                        Unginvestor
                                        wrote on sidst redigeret af
                                        #842

                                        Hej alle. Nu hvor markedet er lukket, kan vi jo bruge tiden på noget lidt andet 🙂 Jeg skal skrive en skoleopgave om en valgfri virksomhed. Det blev selvfølgelig Genmab.. Kan i give mig navne og tal på Genmabs største aktionærer? På forhånd tak 🙂

                                        1 Reply Last reply
                                        0
                                        • BulderB Offline
                                          BulderB Offline
                                          Bulder
                                          wrote on sidst redigeret af
                                          #843

                                          Plesner: Vi forstår ikke, hvorfor der ikke er flere bivirkninger ved dara http://www.vjhemonc.com/video/quvg59hezii-what-are-the-practical-considerations-for-monoclonal-antibody-infusion/?platform=hootsuite

                                          1 Reply Last reply
                                          0

                                          Hello! It looks like you're interested in this conversation, but you don't have an account yet.

                                          Getting fed up of having to scroll through the same posts each visit? When you register for an account, you'll always come back to exactly where you were before, and choose to be notified of new replies (either via email, or push notification). You'll also be able to save bookmarks and upvote posts to show your appreciation to other community members.

                                          With your input, this post could be even better 💗

                                          Tilmeld Log ind

                                          • Log ind

                                          • Har du ikke en konto? Tilmeld

                                          • Login or register to search.
                                          • First post
                                            Last post
                                          0
                                          • Debatforum
                                          • Seneste
                                          • Populære
                                          • Bruger